RXST RxSight, Inc.
Nasdaq · SEC CIK 1111485 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $118.0K 4 sales by 4 insiders
- Filings on record
- 186 since 2021-08-02, latest 2026-09-16 16:25
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Wilterding Mark | CFO | — | $54.0K |
| Kurtz Ronald M MD | Chief Medical Off | — | $35.5K |
| Goldshleger Ilya | See remarks | — | $14.2K |
| Weinberg Eric | See remarks | — | $14.2K |
| Gaines Scott | Chief Customer Off | — | — |
| Fountain Tamara | Dir | — | — |
| Corley Jesse Anderson | Dir | — | — |
| Warner Robert Keith | Dir | — | — |
| Maniar Shweta | Dir | — | — |
| Andrews Julie | Dir | — | — |
Transactions 218
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-02-12 | 2024-02-09 | RXST | Goldshleger Ilya | COO | M - OptEx | $20.90 | +10.4K | 36.8K | +39% | +$216.6K |
| DMT | 2024-02-12 | 2024-02-09 | RXST | Goldshleger Ilya | COO | S - Sale+OE | $50.74 | -10.4K | 31.5K | -25% | -$525.9K |
| DM | 2024-02-07 | 2024-02-05+ | RXST | Thunen Shelley B | CFO | M - OptEx | $12.66 | +31.9K | 29.6K | New | +$403.7K |
| DM | 2024-02-07 | 2024-02-05+ | RXST | Thunen Shelley B | CFO | S - Sale+OE | $47.31 | -25.0K | 13.7K | -65% | -$1.18M |
| 2024-02-07 | 2024-02-05 | RXST | Corley Jesse Anderson | Dir | G - Gift | $0.00 | -46.9K | 30.1K | -61% | $0 | |
| MI | 2024-02-07 | 2024-02-05 | RXST | Corley Jesse Anderson | Dir | G - Gift | $0.00 | +46.9K | 457.5K | +11% | $0 |
| MI | 2024-02-02 | 2024-02-01 | RXST | LINK WILLIAM J PHD | Dir | S - Sale | $49.67 | -28.2K | 31.9K | -47% | -$1.40M |
| I | 2024-02-02 | 2024-02-01 | RXST | LINK WILLIAM J PHD | Dir | G - Gift | $0.00 | -3,000 | 21.2K | -12% | $0 |
| DMT | 2024-02-02 | 2024-02-01 | RXST | Goldshleger Ilya | COO | M - OptEx | $19.24 | +7,129 | 33.6K | +27% | +$137.2K |
| DMT | 2024-02-02 | 2024-02-01 | RXST | Goldshleger Ilya | COO | S - Sale+OE | $49.29 | -7,129 | 26.5K | -21% | -$351.4K |
| TI | 2024-02-02 | 2024-02-01 | RXST | Weinberg Eric | Chief Commercial Off | S - Sale | $50.00 | -10.0K | 300.0K | -3% | -$500.0K |
| DM | 2024-01-29 | 2024-01-26 | RXST | Thunen Shelley B | CFO | M - OptEx | $13.75 | +36.3K | 38.6K | +1,583% | +$498.7K |
| D | 2024-01-29 | 2024-01-26 | RXST | Thunen Shelley B | CFO | S - Sale+OE | $47.11 | -31.8K | 6,791 | -82% | -$1.50M |
| DT | 2024-01-22 | 2024-01-22 | RXST | Goldshleger Ilya | COO | M - OptEx | $18.90 | +5,000 | 31.5K | +19% | +$94.5K |
| DT | 2024-01-22 | 2024-01-22 | RXST | Goldshleger Ilya | COO | S - Sale+OE | $48.00 | -5,000 | 26.5K | -16% | -$240.0K |
| TI | 2024-01-22 | 2024-01-22 | RXST | Weinberg Eric | Chief Commercial Off | S - Sale | $48.00 | -10.0K | 310.0K | -3% | -$480.0K |
| MT | 2024-01-19 | 2024-01-18 | RXST | Maniar Shweta | Dir | S - Sale | $45.72 | -6,399 | 12.1K | -35% | -$292.6K |
| DT | 2024-01-10 | 2024-01-09 | RXST | Goldshleger Ilya | COO | S - Sale+OE | $47.00 | -5,000 | 26.5K | -16% | -$235.0K |
| DT | 2024-01-10 | 2024-01-09 | RXST | Goldshleger Ilya | COO | M - OptEx | $18.90 | +5,000 | 31.5K | +19% | +$94.5K |
| TI | 2024-01-10 | 2024-01-09 | RXST | Weinberg Eric | Chief Commercial Off | S - Sale | $46.00 | -10.0K | 320.0K | -3% | -$460.0K |
| DMT | 2024-01-09 | 2024-01-08 | RXST | Goldshleger Ilya | COO | S - Sale+OE | $43.33 | -15.0K | 31.5K | -32% | -$650.0K |
| DT | 2024-01-09 | 2024-01-08 | RXST | Goldshleger Ilya | COO | M - OptEx | $15.08 | +15.0K | 41.5K | +57% | +$226.2K |
| MTI | 2024-01-09 | 2024-01-08 | RXST | Warner Robert Keith | Dir | S - Sale | $42.69 | -23.8K | 0 | -100% | -$1.01M |
| TI | 2024-01-09 | 2024-01-08 | RXST | Corley Jesse Anderson | Dir | S - Sale | $45.03 | -2,000 | 11.6K | -15% | -$90.1K |
| TI | 2024-01-09 | 2024-01-08 | RXST | Weinberg Eric | Chief Commercial Off | S - Sale | $42.00 | -10.0K | 330.0K | -3% | -$420.0K |
| MTI | 2024-01-09 | 2024-01-08 | RXST | Kurtz Ronald M MD | Pres, CEO, Dir | S - Sale | $44.25 | -62.5K | 804.6K | -7% | -$2.77M |
| T | 2024-01-09 | 2024-01-08 | RXST | Maniar Shweta | Dir | S - Sale | $45.00 | -6,418 | 18.5K | -26% | -$288.8K |
| DMT | 2024-01-03 | 2024-01-02 | RXST | Thunen Shelley B | CFO | S - Sale+OE | $39.24 | -10.0K | 7,772 | -56% | -$392.4K |
| DT | 2024-01-03 | 2024-01-02 | RXST | Thunen Shelley B | CFO | M - OptEx | $15.60 | +10.0K | 12.3K | +436% | +$156.0K |
| I | 2023-12-29 | 2023-12-27 | RXST | Kurtz Ronald M MD | Pres, CEO, Dir | S - Sale | $41.09 | -22.5K | 867.1K | -3% | -$924.5K |
| I | 2023-12-26 | 2023-12-22 | RXST | Weinberg Eric | Chief Commercial Off | S - Sale | $40.00 | -1,285 | 340.0K | -0.4% | -$51.4K |
| D | 2023-12-26 | 2023-12-22 | RXST | Goldshleger Ilya | COO | S - Sale+OE | $40.00 | -5,000 | 26.5K | -16% | -$200.0K |
| D | 2023-12-26 | 2023-12-22 | RXST | Goldshleger Ilya | COO | M - OptEx | $15.08 | +5,000 | 31.5K | +19% | +$75.4K |
| DM | 2023-12-20 | 2023-12-18 | RXST | Goldshleger Ilya | COO | S - Sale+OE | $39.01 | -10.9K | 31.5K | -26% | -$426.7K |
| DM | 2023-12-20 | 2023-12-18 | RXST | Goldshleger Ilya | COO | M - OptEx | $14.14 | +10.9K | 37.4K | +41% | +$154.7K |
| I | 2023-12-19 | 2023-12-15 | RXST | Weinberg Eric | Chief Commercial Off | S - Sale | $40.01 | -8,715 | 341.3K | -2% | -$348.7K |
| MI | 2023-12-18 | 2023-12-14 | RXST | Corley Jesse Anderson | Dir | S - Sale | $40.12 | -12.0K | 13.6K | -47% | -$481.4K |
| D | 2023-12-18 | 2023-12-15 | RXST | Thunen Shelley B | CFO | M - OptEx | $15.60 | +20.0K | 22.3K | +873% | +$312.0K |
| DMI | 2023-12-18 | 2023-12-15 | RXST | Thunen Shelley B | CFO | S - Sale+OE | $39.31 | -20.0K | 38.4K | -34% | -$786.3K |
| D | 2023-12-18 | 2023-12-15 | RXST | Thunen Shelley B | CFO | S - Sale+OE | $39.35 | -20.0K | 2,291 | -90% | -$787.0K |
| MI | 2023-12-18 | 2023-12-14 | RXST | Kurtz Ronald M MD | Pres, CEO, Dir | S - Sale | $39.70 | -40.0K | 909.6K | -4% | -$1.59M |
| MI | 2023-12-12 | 2023-12-08+ | RXST | Warner Robert Keith | Dir | S - Sale | $35.03 | -20.0K | 29.2K | -41% | -$700.6K |
| 2023-11-30 | 2023-11-30 | RXST | Tammenoms Bakker Juliet | Dir | J - Other | $0.00 | +1,617 | 21.8K | +8% | $0 | |
| MI | 2023-11-30 | 2023-11-30 | RXST | Tammenoms Bakker Juliet | Dir | J - Other | $0.00 | -444.7K | 1,548 | -100% | $0 |
| MI | 2023-11-30 | 2023-11-28+ | RXST | Tammenoms Bakker Juliet | Dir | S - Sale | $29.73 | -494.3K | 349.2K | -59% | -$14.69M |
| MI | 2023-11-16 | 2023-11-14+ | RXST | Tammenoms Bakker Juliet | Dir | S - Sale | $27.19 | -500.0K | 494.3K | -50% | -$13.59M |
| MI | 2023-11-15 | 2023-11-13 | RXST | Corley Jesse Anderson | Dir | J - Other | $0.00 | -67.3K | 7,083 | -90% | $0 |
| 2023-11-15 | 2023-11-13 | RXST | Corley Jesse Anderson | Dir | J - Other | $0.00 | +45.7K | 77.0K | +146% | $0 | |
| M | 2023-09-11 | 2023-09-07+ | RXST | Tammenoms Bakker Juliet | Dir | S - Sale | $30.14 | -33.0K | 20.2K | -62% | -$993.0K |
| 2023-08-29 | 2023-08-29 | RXST | Maniar Shweta | Dir | S - Sale | $28.06 | -4,292 | 24.9K | -15% | -$120.4K | |
| 2023-08-28 | 2023-08-25 | RXST | Tammenoms Bakker Juliet | Dir | S - Sale | $29.25 | -16.2K | 53.2K | -23% | -$474.1K | |
| MI | 2023-08-28 | 2023-08-24 | RXST | Tammenoms Bakker Juliet | Dir | J - Other | $0.00 | -266.9K | 445.4K | -37% | $0 |
| 2023-08-28 | 2023-08-24 | RXST | Tammenoms Bakker Juliet | Dir | J - Other | $0.00 | +970 | 69.4K | +1% | $0 | |
| M | 2023-08-18 | 2023-08-17+ | RXST | Tammenoms Bakker Juliet | Dir | S - Sale | $29.62 | -33.1K | 83.1K | -29% | -$981.5K |
| I | 2023-08-18 | 2023-08-17 | RXST | Corley Jesse Anderson | Dir | J - Other | $0.00 | +81.5K | 81.5K | New | $0 |
| 2023-08-18 | 2023-08-17 | RXST | Corley Jesse Anderson | Dir | J - Other | $0.00 | +1,204 | 31.3K | +4% | $0 | |
| MI | 2023-08-18 | 2023-08-17 | RXST | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -672.9K | 0 | -100% | $0 |
| 2023-08-18 | 2023-08-17 | RXST | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | +2,610 | 24.5K | +12% | $0 | |
| 2023-08-11 | 2023-08-09 | RXST | Tammenoms Bakker Juliet | Dir | J - Other | $0.00 | +33.0K | 101.5K | +48% | $0 | |
| I | 2023-08-11 | 2023-08-09 | RXST | Tammenoms Bakker Juliet | Dir | J - Other | $0.00 | -497.1K | 994.3K | -33% | $0 |
| D | 2023-07-27 | 2023-07-26 | RXST | Goldshleger Ilya | COO | M - OptEx | $3.93 | +25.5K | 26.5K | +2,548% | +$100.1K |
| 2023-06-16 | 2023-06-14 | RXST | Tammenoms Bakker Juliet | Dir | J - Other | $0.00 | +1,022 | 68.6K | +2% | $0 | |
| MI | 2023-06-16 | 2023-06-14 | RXST | Tammenoms Bakker Juliet | Dir | J - Other | $0.00 | -266.9K | 712.7K | -27% | $0 |
| 2023-06-05 | 2023-06-01 | RXST | Corley Jesse Anderson | Dir | A - Grant | $0.00 | +5,731 | 30.1K | +24% | $0 | |
| 2023-06-05 | 2023-06-01 | RXST | Tammenoms Bakker Juliet | Dir | A - Grant | $0.00 | +5,731 | 67.6K | +9% | $0 | |
| 2023-06-05 | 2023-06-01 | RXST | Maniar Shweta | Dir | A - Grant | $0.00 | +5,731 | 29.2K | +24% | $0 | |
| 2023-06-05 | 2023-06-01 | RXST | LINK WILLIAM J PHD | Dir | A - Grant | $0.00 | +5,731 | 21.9K | +35% | $0 | |
| 2023-06-05 | 2023-06-01 | RXST | Andrews Julie | Dir | A - Grant | $0.00 | +5,731 | 43.4K | +15% | $0 | |
| 2023-06-05 | 2023-06-01 | RXST | Fountain Tamara | Dir | A - Grant | $0.00 | +5,731 | 29.2K | +24% | $0 | |
| 2023-06-05 | 2023-06-01 | RXST | PALMISANO ROBERT J | Dir | A - Grant | $0.00 | +5,731 | 27.7K | +26% | $0 | |
| 2023-06-05 | 2023-06-01 | RXST | Warner Robert Keith | Dir | A - Grant | $0.00 | +5,731 | 27.7K | +26% | $0 | |
| 2023-05-31 | 2023-05-26 | RXST | Tammenoms Bakker Juliet | Dir | J - Other | $0.00 | +33.1K | 61.8K | +115% | $0 | |
| I | 2023-05-31 | 2023-05-26 | RXST | Tammenoms Bakker Juliet | Dir | J - Other | $0.00 | -497.1K | 1.49M | -25% | $0 |
| MI | 2023-05-12 | 2023-05-11 | RXST | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -159.7K | 0 | -100% | $0 |
| I | 2023-02-13 | 2023-02-10 | RXST | Tammenoms Bakker Juliet | Dir | P - Purchase | $12.50 | +480.0K | 980.0K | +96% | +$6.00M |
| 2023-02-13 | 2023-02-10 | RXST | Kurtz Ronald M MD | Pres, CEO, Dir | A - Grant | $12.50 | +40.0K | 40.0K | New | +$500.0K | |
| M | 2023-01-23 | 2023-01-19 | RXST | Fountain Tamara | Dir | A - Grant | $0.00 | +23.5K | 19.2K | New | $0 |
| MI | 2022-11-14 | 2022-11-09 | RXST | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -209.5K | 258.4K | -45% | $0 |
| MI | 2022-08-11 | 2022-08-10 | RXST | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -209.5K | 488.2K | -30% | $0 |
| MI | 2022-06-09 | 2022-06-08 | RXST | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -248.0K | 891.8K | -22% | $0 |
| AI | 2022-06-08 | 2022-05-17 | RXST | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | +127.0K | 254.0K | +100% | $0 |
| AI | 2022-06-08 | 2022-03-15 | RXST | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | +127.0K | 127.0K | New | $0 |
| 2022-06-03 | 2022-06-02 | RXST | LINK WILLIAM J PHD | Dir | A - Grant | $0.00 | +10.3K | 47.5K | +28% | $0 | |
| 2022-06-03 | 2022-06-02 | RXST | Warner Robert Keith | Dir | A - Grant | $0.00 | +8,624 | 22.0K | +64% | $0 | |
| 2022-06-03 | 2022-06-02 | RXST | PALMISANO ROBERT J | Dir | A - Grant | $0.00 | +8,624 | 22.0K | +64% | $0 | |
| 2022-06-03 | 2022-06-02 | RXST | Andrews Julie | Dir | A - Grant | $0.00 | +8,624 | 37.6K | +30% | $0 | |
| 2022-06-03 | 2022-06-02 | RXST | Tammenoms Bakker Juliet | Dir | A - Grant | $0.00 | +10.3K | 28.7K | +56% | $0 | |
| 2022-06-03 | 2022-06-02 | RXST | Corley Jesse Anderson | Dir | A - Grant | $0.00 | +10.3K | 24.4K | +74% | $0 | |
| 2022-06-03 | 2022-06-02 | RXST | Maniar Shweta | Dir | A - Grant | $0.00 | +4,312 | 23.5K | +22% | $0 | |
| I | 2022-05-19 | 2022-05-17 | RXST | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -375.0K | 1.27M | -23% | $0 |
| I | 2022-03-17 | 2022-03-15 | RXST | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -375.0K | 1.64M | -19% | $0 |
| 2022-01-05 | 2022-01-03 | RXST | Maniar Shweta | Dir | A - Grant | $0.00 | +19.2K | 19.2K | New | $0 | |
| 2021-11-18 | 2021-11-17 | RXST | Corley Jesse Anderson | Dir | P - Purchase | $12.49 | +8,150 | 14.0K | +139% | +$101.8K | |
| 2021-08-06 | 2021-08-05 | RXST | Goldshleger Ilya | COO | P - Purchase | $14.49 | +1,000 | 1,000 | New | +$14.5K | |
| I | 2021-08-06 | 2021-08-05 | RXST | Goldshleger Ilya | COO | P - Purchase | $13.69 | +1,372 | 1,372 | New | +$18.8K |
| MI | 2021-08-06 | 2021-07-30+ | RXST | Weinberg Eric | Chief Commercial Off | P - Purchase | $16.47 | +925 | 301 | New | +$15.2K |
| I | 2021-08-05 | 2021-08-03 | RXST | Corley Jesse Anderson | Dir | P - Purchase | $16.00 | +78.1K | 436.2K | +22% | +$1.25M |
| I | 2021-08-05 | 2021-08-03 | RXST | Warner Robert Keith | Dir | P - Purchase | $16.00 | +43.8K | 57.1K | +327% | +$700.0K |
| M | 2021-08-05 | 2021-08-03 | RXST | Warner Robert Keith | Dir | A - Grant | $0.00 | +13.4K | 13.4K | New | $0 |
| 2021-08-05 | 2021-08-03 | RXST | Kurtz Ronald M MD | See Remarks, Dir | P - Purchase | $16.00 | +125.0K | 125.0K | New | +$2.00M |
Purchase Sale Sale after option exercise All abbreviations